Javascript must be enabled to continue!
PoPMuSiC, rationally designing point mutations in protein structures
View through CrossRef
Abstract
Summary: PoPMuSiC is an efficient tool for rational computer-aided design of single-site mutations in proteins and peptides. Two types of queries can be submitted. The first option allows to estimate the changes in folding free energy for specific point mutations given by the user. In the second option, all possible point mutations in a given protein or protein region are performed and the most stabilizing or destabilizing mutations, or the neutral mutations with respect to thermodynamic stability, are selected. For each sequence position or secondary structure the deviation from the most stable sequence is moreover evaluated, which helps to identify the most suitable sites for the introduction of mutations.
Availability: http://babylone.ulb.ac.be/popmusic
Contact: jean.marc.kwasigroch@ulb.ac.be
* To whom correspondence should be addressed.
Title: PoPMuSiC, rationally designing point
mutations in protein structures
Description:
Abstract
Summary: PoPMuSiC is an efficient tool for rational computer-aided design of single-site mutations in proteins and peptides.
Two types of queries can be submitted.
The first option allows to estimate the changes in folding free energy for specific point mutations given by the user.
In the second option, all possible point mutations in a given protein or protein region are performed and the most stabilizing or destabilizing mutations, or the neutral mutations with respect to thermodynamic stability, are selected.
For each sequence position or secondary structure the deviation from the most stable sequence is moreover evaluated, which helps to identify the most suitable sites for the introduction of mutations.
Availability: http://babylone.
ulb.
ac.
be/popmusic
Contact: jean.
marc.
kwasigroch@ulb.
ac.
be
* To whom correspondence should be addressed.
Related Results
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
Abstract
Background
Recent reports have highlighted an adverse impact of TP53 mutations on the prognosis of patients with myeloid malignancies. TP53 m...
Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms
Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms
Abstract
Recurrent somatic mutations of CUX1 are described in myeloid neoplasms. CUX1 is located at chromosome 7q22.1; -7/del(7q) involving CUX1 locus are common abn...
Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia
Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia
Abstract
Abstract 1419
Aims:
Molecular pathogenesis of acute lymphoblastic leukemia (ALL) has largely been verifi...
Distinct Profile of FLT3 Mutations in Brazil.
Distinct Profile of FLT3 Mutations in Brazil.
Abstract
Mutations in the tyrosine kinase receptor FLT3 are the most common molecular abnormality in acute myeloid leukemia (AML) being detected in about 30% of AML ...
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Abstract
Introduction. Ultra-deep next generation sequencing (NGS) allows sensitive detection of mutations and estimation of their clonal abundance in tumor cell pop...
Analysis of Molecular Minimal Residual Disease in Patients with Acute Leukemia during Complete Remission
Analysis of Molecular Minimal Residual Disease in Patients with Acute Leukemia during Complete Remission
Abstract
Introduction: Acute leukemia is a group of clonal heterogeneous diseases with high recurrence rate. The monitoring of minimal residual disease (MRD) after t...

